Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
20 October 2023 | Story Samkelo Fetile
2023 UFS Thought-Leader Webinar Series

The University of the Free State (UFS) is pleased to present a panel discussion titled, Student protest action, politics, and higher education, which is part of the 2023 Thought-Leader Webinar Series. Join Prof Adam Habib and Dr Max Price for a discussion about their respective experiences in leadership positions during the #RhodesMustFall and #FeesMustFall student protest movements, the lessons learnt during these tumultuous times, and how these events continue to influence the current landscape in the higher education sector in South Africa and further afield. The discussion will reflect on their recent books Rebels and Rage: Reflecting on #FeesMustFall, and Statues and Storms, and will be facilitated by Prof Francis Petersen, the Vice-Chancellor and Principal of the UFS.


Date:   Tuesday 21 November 2023

Time: 13:00-14:30

Click to view document WATCH: vimeo.com/kovsies/tls23

For further information, contact Alicia Pienaar at pienaaran1@ufs.ac.za.


Some of the topics discussed by leading experts in 2022 included, Crime in South Africa – who is to blame; Are our glasses half full or half empty; What needs to be done to power up South Africa; A look into the future of South Africa. This year’s webinar series commenced with a discussion on Threats to South Africa’s stability and security challenges, followed by A culture of acceptance – is this South Africa’s greatest threat? and The need for a global and regional plan / approach to respond to the consequences of the Russia-Ukraine war.


Facilitator:

Prof Francis Petersen

Vice-Chancellor and Principal, UFS

 

Panellists:

Prof Adam Habib

Director: School of Oriental and African Studies, University of London

 

Dr Max Price

Emeritus Vice-Chancellor, University of Cape Town; academic and consultant

 

Bios of speakers:

 

Prof Adam Habib

Prof Adam Habib is an academic, researcher, activist, administrator, and well-known public intellectual. A Professor of Political Science, Prof Habib has more than 30 years of academic, research, and administration expertise, spanning five universities and multiple local and international institutions.

Prior to his appointment as Director of SOAS, he was Vice-Chancellor and Principal of the University of the Witwatersrand (Wits) in Johannesburg, South Africa between 2013 and 2020. He has also served as Deputy Vice-Chancellor of Research at the University of Johannesburg, Executive Director of Democracy and Governance at the Human Sciences Research Council, and as Director of the Centre for Civil Society and Professor of Development at the University of KwaZulu-Natal. He is widely published, including his two well-received monographs, South Africa's Suspended Revolution: Hopes and Prospects and Rebels and Rage: Reflecting on #FeesMustFall.

Prof Habib’s academic contributions resulted in his election to the American Academy of Arts and Sciences, in addition to serving as a fellow of both the African Academy of Sciences and the Academy of Science of South Africa. He also serves on the Council of the United Nations University.

 

Dr Max Price

Dr Max Price was appointed Vice-Chancellor of the University of Cape Town in July 2008, completing his ten-year term in June 2018. During the first seven years of his term, UCT experienced growth and success in research and teaching, as well as global recognition. This continued during the last three years but was overshadowed by the Rhodes Must Fall and Fees Must Fall protests during 2015 to 2017. Dr Price led the university through these storms and back to safe harbour in 2018.

Dr Price studied Medicine at the University of the Witwatersrand (Wits), during which time he became deeply involved in student politics, becoming SRC president a year after the Soweto uprising. He subsequently did a PPE degree at Oxford as a Rhodes Scholar. Following clinical work in academic and rural hospitals in South Africa, he gained a master’s degree in Community Health at the London School of Hygiene and Tropical Medicine, and then worked as an academic in the areas of health policy and economics, rural health services, and health science education.

He was dean of the Faculty of Health Sciences at Wits for ten years. He now consults in public health, higher education, strategic leadership, and advises foundations on grant making. He is currently a scholar in residence at the Atlantic Institute. He is the author of Statues and Storms: Leading through change, published in 2023.

News Archive

#Women'sMonth: Save the children
2017-08-10

Description: Trudi O'Neill Tags: : rotaviruses, young children, Dr Trudi O’Neill, Department of Microbial, Biochemical and Food Biotechnology, vaccine 

Dr Trudi O’Neill, Senior lecturer in the Department of
Microbial, Biochemical and Food Biotechnology.
Photo: Anja Aucamp

Dr Trudi O’Neill, Senior lecturer in the Department of Microbial, Biochemical and Food Biotechnology, is conducting research on rotavirus vaccines.

Dr O’Neill was inspired to conduct research on this issue through her fascination with the virus. “The biology of rotaviruses, especially the genome structure and the virus’ interaction with the host, is fascinating.”

“In fact, it is estimated that, globally, ALL children will be infected with rotavirus before the age of five, irrespective of their socio-economic standing. However, infants and young children in poor countries are more vulnerable due to inadequate healthcare. The WHO estimates that approximately 215 000 deaths occur each year. This roughly equates to eight Airbus A380 planes, the largest commercial carrier with a capacity of approximately 500 seats, filled with only children under the age of five, crashing each week of every year.”

Alternative to expensive medicines 
“Currently, there are two vaccines that have been licensed for global use. However, these vaccines are expensive and poor countries, where the need is the greatest, are struggling to introduce them sustainably. It is therefore appealing to study rotaviruses, as it is scientifically challenging, but could at the same time have an impact on child health,” Dr O’Neill said.

The main focus of Dr O’Neill’s research is to develop a more affordable vaccine that can promote child vaccination in countries/areas that cannot afford the current vaccines.

All about a different approach 

When asked about the most profound finding of her research, Dr O’Neill responded: “It is not so much a finding, but rather the approach. My rotavirus research group is making use of yeast as vehicle to produce a sub-unit vaccine. These microbes are attractive, as they are relatively easy to manipulate and cheap to cultivate. Downstream production costs can therefore be reduced. The system we use was developed by my colleagues, Profs Koos Albertyn and Martie Smit, and allows for the potential use of any yeast. This enables us to screen a vast number of yeasts in order to identify the best yeast producer.”

Vaccination recently acquired a bad name in the media for its adverse side effects. As researcher, Dr O’Neill has this to say: “Vaccines save lives. By vaccinating your child, you don’t just protect your own child from a potentially deadly infection, but also other children in your community that might be too young to be vaccinated or have pre-existing health problems that prevents vaccination.” 

A future without rotavirus vaccination?

Dr O’Neill believes a future without rotavirus vaccination will be a major step backwards, as the impact of rotavirus vaccines has been profound. “Studies in Mexico and Malawi actually show a reduction in deaths. A colleague in Mozambique has commented on the empty hospital beds that amazed both clinicians and scientists only one year after the introduction of the vaccine in that country. Although many parents, mostly in developed countries, don’t have to fear dehydrating diarrhoea and potential hospitalisation of their babies due to rotavirus infection anymore, such an infection could still be a death sentence in countries that have not been able to introduce the vaccine in their national vaccination programmes,” she said. 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept